Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.
Physicians from Accentia and Johns Hopkins University present plans for new MS drug study for Cyrevia
Value and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000.
Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR.
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
The Inaugural Hillel Panitch, MD Multiple Sclerosis Symposium
Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis.
A novel pH-sensitive interferon-β (INF-β) oral delivery system for application in multiple sclerosis.
ALSUntangled No. 8: Low dose naltrexone for ALS.
Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
Genzyme’s Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine.
Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy.
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.

Pages